Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Goren

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1986
Increased levels of urinary adenosine deaminase binding protein in children treated with cisplatin or methotrexateM P Goren, R K Wright, M E Horowitz
American Journal of Obstetrics and Gynecology|October 1, 1987
Increased tubular enzyme excretion in preeclampsiaM P Goren, B M Sibai, A el-Nazar
Cancer Chemotherapy and Pharmacology|January 1, 1989
Tubular nephrotoxicity during long-term ifosfamide and mesna therapyM P Goren, C B Pratt, M J Viar
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Lancet (London, England)|November 22, 1986
Dechloroethylation of ifosfamide and neurotoxicityM P Goren, R K Wright, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumorsC B Pratt, M P Goren, W H Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexateM P Goren, R K Wright, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neckA A Forastiere, R B Natale, B J Takasugi, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1986
Increased levels of urinary adenosine deaminase binding protein in children treated with cisplatin or methotrexateM P Goren, R K Wright, M E Horowitz
American Journal of Obstetrics and Gynecology|October 1, 1987
Increased tubular enzyme excretion in preeclampsiaM P Goren, B M Sibai, A el-Nazar
Cancer Chemotherapy and Pharmacology|January 1, 1989
Tubular nephrotoxicity during long-term ifosfamide and mesna therapyM P Goren, C B Pratt, M J Viar
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Lancet (London, England)|November 22, 1986
Dechloroethylation of ifosfamide and neurotoxicityM P Goren, R K Wright, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumorsC B Pratt, M P Goren, W H Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexateM P Goren, R K Wright, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neckA A Forastiere, R B Natale, B J Takasugi, et al.
Pageof 5